A new trading day began on Tuesday, with Oruka Therapeutics Inc (NASDAQ: ORKA) stock price down -6.82% from the previous day of trading, before settling in for the closing price of $10.26. ORKA’s price has ranged from $9.44 to $33.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 39.53%. With a float of $31.69 million, this company’s outstanding shares have now reached $37.44 million.
In an organization with 28 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Oruka Therapeutics Inc (ORKA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Oruka Therapeutics Inc is 15.35%, while institutional ownership is 71.87%. The most recent insider transaction that took place on Feb 14 ’25, was worth 1,015,803. In this transaction 10% Owner of this company bought 88,794 shares at a rate of $11.44, taking the stock ownership to the 4,148,428 shares. Before that another transaction happened on Feb 13 ’25, when Company’s 10% Owner bought 14,950 for $11.63, making the entire transaction worth $173,868. This insider now owns 4,059,634 shares in total.
Oruka Therapeutics Inc (ORKA) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.52 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 39.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.79% during the next five years compared to 36.88% growth over the previous five years of trading.
Oruka Therapeutics Inc (NASDAQ: ORKA) Trading Performance Indicators
Here are Oruka Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 28.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.43, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -2.56 in one year’s time.
Technical Analysis of Oruka Therapeutics Inc (ORKA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.3 million. That was better than the volume of 0.27 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 38.97%. Additionally, its Average True Range was 1.02.
During the past 100 days, Oruka Therapeutics Inc’s (ORKA) raw stochastic average was set at 3.16%, which indicates a significant decrease from 16.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 102.11% in the past 14 days, which was higher than the 86.95% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.52, while its 200-day Moving Average is $25.00. However, in the short run, Oruka Therapeutics Inc’s stock first resistance to watch stands at $10.25. Second resistance stands at $10.94. The third major resistance level sits at $11.59. If the price goes on to break the first support level at $8.91, it is likely to go to the next support level at $8.26. The third support level lies at $7.57 if the price breaches the second support level.
Oruka Therapeutics Inc (NASDAQ: ORKA) Key Stats
With a market capitalization of 357.93 million, the company has a total of 37,441K Shares Outstanding. Currently, annual sales are 0 K while annual income is -83,720 K. The company’s previous quarter sales were 0 K while its latest quarter income was -50,410 K.
